XM không cung cấp dịch vụ cho cư dân của Mỹ.
B
B

Baloise


Tin tức

Baloise Sells Friday Portfolio

BRIEF-Baloise Sells Friday Portfolio Oct 29 (Reuters) - Baloise Holding AG BALN.S : SELLS FRIDAY PORTFOLIO PARTIES HAVE AGREED NOT TO DISCLOSE PURCHASE PRICE WE ANTICIPATE A ONE-OFF NEGATIVE IMPACT ON EARNINGS OF AROUND CHF 75 MILLION, MOST OF WHICH WILL BE RECOGNISED IN 2024 Further company coverage: BALN.S (Gdansk Newsroom) ;))
B

Top of the Street: Ubisoft, Swiss insurers

BUZZ-Top of the Street: Ubisoft, Swiss insurers A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** HSBC downgrades French video game maker Ubisoft UBIP.PA to "hold" from "buy" and cuts PT by 66% to EUR 10.8, citing Wednesday's profit warning and execution risks, and says there remain risks to earnings in the near term INITIATIONS AND REINSTATEMENTS ** Deutsche Bank initiates Baloise BALN.S with "buy", Helvetia HSPF.S with "hold" and Swiss Life SLHN.S with "
B
D
H
U
S

Big Technologies, Safran, Volution Group

EUROPE RESEARCH ROUNDUP-Big Technologies, Safran, Volution Group Sept 27 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Big Technologies, Safran and Volution Group on Friday. HIGHLIGHTS * 3I Group III.L : Citigroup raises target price to 4140p from 3850p * Big Technologies Plc BIGB.L : Peel Hunt raises to add from hold * Safran SAF.PA : Jefferies raises target price to EUR 220 from EUR 205 * Solar Foods Oyj SFOODS.HE : Inderes rai
3
A
A
B
B
C
D
F
H
L
S
S
S
S
T
U
H
A
F
S

Burberry, Experian, GEA Group

EUROPE RESEARCH ROUNDUP- Burberry, Experian, GEA Group Sept 26 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Burberry, Experian and GEA Group, on Thursday. HIGHLIGHTS * Burberry BRBY.L : RBC cuts target price to 650p from 800p * Experian EXPN.L : RBC raises to sector perform from underperform * FACC AG FACC.VI : Kepler Cheuvreux raises to buy from hold * GEA Group AG G1AG.DE : Morgan Stanley raises to overweight from equal-weight
B
B
B
E
E
G
H
K
K
L
M
P
R
S
S
U
U
P

JPM says strong non-life businesses justify Swiss insurers' premium valuations

BUZZ-JPM says strong non-life businesses justify Swiss insurers' premium valuations ** J.P.Morgan says Swiss insurers' valuation premiums vs European peers are justified, as their high-quality non-life and fee-based products have ensured strong margins, attractive cash flow and growth over the past decade ** That has offset slower growth in their l
B
H
S

Air France-KLM, Burberry, Wise

EUROPE RESEARCH ROUNDUP- Air France-KLM, Burberry, Wise Sept 25 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Air France-KLM, Burberry and Wise, on Wednesday. HIGHLIGHTS * Air France-KLM AIRF.PA : JP Morgan raises to overweight from underweight * Burberry BRBY.L : JP Morgan cuts target price to 650p from 800p * Helvetia Holding HELN.S : JP Morgan places stock on its positive catalyst watch list * Orion Oyj ORNBV.HE : Jefferies ra
A
B
B
B
B
B
E
H
H
K
K
A
J
S

Swiss stocks - Factors to watch on September 25

Swiss stocks - Factors to watch on September 25 ZURICH/GDANSK, Sept 25 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Wednesday: COMPANY STATEMENTS LECLANCHE SA LECN.S and Pinnacle will establish a joint venture company funded by pinnacle for an amount of up to 360 million Swiss francs. ANALYSTS' VIEWS HELVETIA HOLDING AG HELN.S - JP MORGAN INITIATES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE CHF 170; PLACES STOCK ON ITS POSITIVE CATALYST WATCH LIST SWISS LIFE H
B
H
S

Vontobel assesses obesity drugs impact for Swiss insurers, med-tech companies

BUZZ-Vontobel assesses obesity drugs impact for Swiss insurers, med-tech companies ** Vontobel estimates the market potential for obesity drugs in the U.S. to reach a three-digit billion U.S. dollar amount and picks Swiss Re SRENH.S and Ypsomed YPSN.S as the most likely to profit from it ** Among Swiss life insurers, Swiss Re could benefit the most from a rising demand in life and health reinsurance, with a market share of about 15%, as obesity drugs improve life expectancy, it says ** Its posit
B
H
N
R
S
S
Z

MTU Aero Engines, Nestle, Vusiongroup

EUROPE RESEARCH ROUNDUP- MTU Aero Engines, Nestle, Vusiongroup Sept 16 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including MTU Aero Engines, Nestle and Vusiongroup, on Monday. HIGHLIGHTS * Advanced Medical Solutions Group Plc AMSU.L : Peel Hunt raises target to 246p from 220p * MTU Aero Engines AG MTXGn.DE : Citigroup cuts to sell from neutral * Nestle SA NESN.S : Morgan Stanley cuts to underweight from equal-weight * Sodexo EXHO.PA : B
A
A
B
B
C
D
I
I
M
M
N
N
S
A
A
P

Swiss stocks - Factors to watch on September 16

Swiss stocks - Factors to watch on September 16 ZURICH/GDANSK, Sept 16(Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday: SOFTWAREONE HOLDING SWON.S Swiss technology firm was exploring a potential merger with smaller Norwegian competitor Crayon Group Holding CRAYN.OL , Bloomberg News reported on Friday, citing people familiar with the matter.
B

Baloise's new strategy not bold enough, say investors

Baloise's new strategy not bold enough, say investors By Oliver Hirt ZURICH, Sept 13 (Reuters) - Investors in Baloise BALN.S say the Swiss insurer's plans to shake up its business with bigger returns to shareholders and job cuts are unlikely to be enough to satisfy the market, and it may end up having to sell parts of its business. Baloise unveiled its strategy on Thursday and said it could also consider share buybacks next year.
B

Activist investor Cevian unimpressed by Baloise proposals

Activist investor Cevian unimpressed by Baloise proposals ZURICH, Sept 12 (Reuters) - Activist investor Cevian on Thursday said it was unimpressed by Baloise's proposals BALN.S to improve performance at the Swiss insurer. "For Baloise to become a great Swiss insurance company, real focus and real ambition are needed," said Cevian partner Robert Schuchna.
B

Baloise eyeing changes in board of directors, chairman says

UPDATE 1-Baloise eyeing changes in board of directors, chairman says Adds details throughout By Oliver Hirt ZURICH, Sept 12 (Reuters) - Swiss insurer Baloise BALN.S is considering changes in its board of directors, Chairman Thomas von Planta said on Thursday after the company revealed plans to boost returns to shareholders. "We want to strengthen the insurance expertise on the board," von Planta told Reuters in an interview.
B

Baloise eyeing changes in board of directors, chairman says

Baloise eyeing changes in board of directors, chairman says ZURICH, Sept 12 (Reuters) - Swiss insurer Baloise BALN.S is considering changes in its board of directors, Chairman Thomas von Planta said on Thursday after the company revealed plans to boost returns to shareholders. "We want to strengthen the insurance expertise on the board," von Planta told Reuters in an interview.
B

Swiss insurer Baloise targets higher shareholder returns after Cevian move

UPDATE 5-Swiss insurer Baloise targets higher shareholder returns after Cevian move Baloise to boost return on equity, cut jobs, considers buybacks CEO emphasizes efficiency and core business performance Chairman says board changes under consideration Adds comment from Cevian, paragraphs 2, 6-7 By Oliver Hirt ZURICH, Sept 12 (Reuters) - Swiss insurer Baloise BALN.S said on Thursday it plans to boost return on equity, cut jobs and will consider share buybacks after Swedish activist investor Cevia
B

Baloise targets higher returns for shareholders after Cevian move

Baloise targets higher returns for shareholders after Cevian move ZURICH, Sept 12 (Reuters) - Swiss insurer Baloise BALN.S said on Thursday it plans to boost return on equity and will consider share buybacks after activist investor Cevian Capital this week revealed it held over 9% of the company's stock, becoming its top stakeholder. Baloise said in a statement that its new targets include a return on equity of 12% to 15%, cash remittance of more than 2 billion Swiss francs ($2.34 billion) in th
B

Baloise Volume Of Business Stood At CHF 5.29 Bln

BRIEF-Baloise Volume Of Business Stood At CHF 5.29 Bln Sept 12 (Reuters) - BALOISE HOLDING AG BALN.S : BALOISE GENERATES GROWTH IN ITS ATTRACTIVE NON-LIFE BUSINESS AND REPORTS AN ENCOURAGING PROFIT DESPITE HIGHER CLAIMS INCURRED VOLUME OF BUSINESS STOOD AT CHF 5,293.0 MILLION (H1 2023: CHF 5,339.9 MILLION) PROFIT ATTRIBUTABLE TO SHAREHOLDERS FOR FI
B

Baloise Launches Its Refocusing Strategy

BRIEF-Baloise Launches Its Refocusing Strategy Sept 12 (Reuters) - BALOISE HOLDING AG BALN.S : BALOISE LAUNCHES ITS REFOCUSING STRATEGY, RAISES PAYOUT RATE AND AIMS FOR A RETURN ON EQUITY OF BETWEEN 12 PER CENT AND 15 PER CENT ANNOUNCING START OF A REFOCUSING STRATEGY THAT INCLUDES MEASURES RELATED TO TECHNICAL PROFITABILITY, OPERATIONAL EFFICIENCY
B

Swiss stocks - Factors to watch on September 12

Swiss stocks - Factors to watch on September 12 ZURICH/GDANSK, Sep 12(Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: Roche ROG.S Roche said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its shares in July were based on just six patients, underscoring the uncertainty of the development project.
B
R
S

Investors press Baloise to shake up business after Cevian swoop

Investors press Baloise to shake up business after Cevian swoop By Oliver Hirt and Paul Arnold ZURICH, Sept 10 (Reuters) - Swiss insurer Baloise BALN.S is under pressure to heed shareholder demands to shake up its portfolio and boost returns since activist investor Cevian Capital said it held over 9% of the company's stock, becoming its biggest stakeholder.
A
B
H
A
A
S
Z



Các điều kiện

Các tài sản phổ thông

Khước từ trách nhiệm: các tổ chức thuộc XM Group chỉ cung cấp dịch vụ khớp lệnh và truy cập Trang Giao dịch trực tuyến của chúng tôi, cho phép xem và/hoặc sử dụng nội dung có trên trang này hoặc thông qua trang này, mà hoàn toàn không có mục đích thay đổi hoặc mở rộng. Việc truy cập và sử dụng như trên luôn phụ thuộc vào: (i) Các Điều kiện và Điều khoản; (ii) Các Thông báo Rủi ro; và (iii) Khước từ trách nhiệm toàn bộ. Các nội dung như vậy sẽ chỉ được cung cấp dưới dạng thông tin chung. Đặc biệt, xin lưu ý rằng các thông tin trên Trang Giao dịch trực tuyến của chúng tôi không phải là sự xúi giục, mời chào để tham gia bất cứ giao dịch nào trên các thị trường tài chính. Giao dịch các thị trường tài chính có rủi ro cao đối với vốn đầu tư của bạn.

Tất cả các tài liệu trên Trang Giao dịch trực tuyến của chúng tôi chỉ nhằm các mục đích đào tạo/cung cấp thông tin và không bao gồm - và không được coi là bao gồm - các tư vấn tài chính, đầu tư, thuế, hoặc giao dịch, hoặc là một dữ liệu về giá giao dịch của chúng tôi, hoặc là một lời chào mời, hoặc là một sự xúi giục giao dịch các sản phẩm tài chính hoặc các chương trình khuyến mãi tài chính không tự nguyện.

Tất cả nội dung của bên thứ ba, cũng như nội dung của XM như các ý kiến, tin tức, nghiên cứu, phân tích, giá cả, các thông tin khác hoặc các đường dẫn đến trang web của các bên thứ ba có trên trang web này được cung cấp với dạng "nguyên trạng", là các bình luận chung về thị trường và không phải là các tư vấn đầu tư. Với việc các nội dung đều được xây dựng với mục đích nghiên cứu đầu tư, bạn cần lưu ý và hiểu rằng các nội dung này không nhằm mục đích và không được biên soạn để tuân thủ các yêu cầu pháp lý đối với việc quảng bá nghiên cứu đầu tư này và vì vậy, được coi như là một tài liệu tiếp thị. Hãy chắc chắn rằng bạn đã đọc và hiểu Thông báo về Nghiên cứu Đầu tư không độc lập và Cảnh báo Rủi ro tại đây liên quan đến các thông tin ở trên.

Cảnh báo rủi ro: Vốn của bạn bị rủi ro. Các sản phẩm có đòn bẩy có thể không phù hợp với tất cả mọi người. Hãy xem kỹ Thông báo rủi ro của chúng tôi.